Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients With Type 2 Diabetes Not Controlled With Metformin

Internal Medicine - Japan
doi 10.2169/internalmedicine.52.8175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine


Related search